Literature DB >> 16986017

Interventions for detrusor overactivity: the case for multimodal therapy.

Roger Dmochowski.   

Abstract

Viable therapeutic alternatives for the management of overactive bladder (OAB) have recently evolved that provide satisfactory symptomatic control for the majority of patients. However, the presupposition that interventions exist as stand-alone entities is not representative of experience in unique populations with the therapeutic benefit of combination therapy, using components drawn from behavioral, physiotherapeutic, neuromodulatory, and, if necessary, surgical alternatives. Even in populations relatively refractory to therapy, the use of multimodal therapy yields additive benefits for patients with OAB symptoms. Herein is detailed the evidence supporting the concept that multimodal therapy provides optimal benefit to patients suffering from this symptom complex.

Entities:  

Year:  2002        PMID: 16986017      PMCID: PMC1476017     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  37 in total

1.  Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated.

Authors:  C J Fowler; M J Swinn; R J Goodwin; S Oliver; M Craggs
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

2.  Partial denervation of the bladder, A new operation for the treatment of urge incontinence and similar conditions in women.

Authors:  A INGELMAN-SUNDBERG
Journal:  Acta Obstet Gynecol Scand       Date:  1959       Impact factor: 3.636

3.  Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant.

Authors:  R A Janknegt; E H Weil; P H Eerdmans
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

4.  Idiopathic bladder instability treated by biofeedback.

Authors:  L D Cardozo; P D Abrams; S L Stanton; R C Feneley
Journal:  Br J Urol       Date:  1978-12

5.  Biofeedback: a 5-year review.

Authors:  L D Cardozo; S L Stanton
Journal:  Br J Urol       Date:  1984-04

6.  An interdisciplinary approach to the assessment and behavioral treatment of urinary incontinence in geriatric outpatients.

Authors:  B J McDowell; K L Burgio; M Dombrowski; J L Locher; E Rodriguez
Journal:  J Am Geriatr Soc       Date:  1992-04       Impact factor: 5.562

7.  Transcutaneous sacral neurostimulation for irritative voiding dysfunction.

Authors:  I K Walsh; R S Johnston; P F Keane
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

8.  Bladder distension in the management of detrusor instability.

Authors:  L Jørgensen; S O Mortensen; H Colstrup; J T Andersen
Journal:  Scand J Urol Nephrol       Date:  1985

9.  Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group.

Authors:  J F Wyman; J A Fantl; D K McClish; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

10.  Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder.

Authors:  S Herschorn; R J Hewitt
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

View more
  3 in total

1.  Triple therapy in refractory detrusor overactivity: a preliminary study.

Authors:  Ricardo Natalin; Leonardo Oliveira Reis; Cristiano Alpendre; Lia Y Ikari; Alessandro Prudente; Carlos A L D'Ancona
Journal:  World J Urol       Date:  2009-03-18       Impact factor: 4.226

2.  Successful use of sacral neuromodulation after failed bladder augmentation.

Authors:  Nathan T Rasmussen; Michael L Guralnick; R Corey O'Connor
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

3.  Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil.

Authors:  Luis Augusto Seabra Rios; Marcio Augusto Averbeck; Wagner Franca; Carlos Alberto Ricetto Sacomani; Fernando G Almeida; Cristiano Mendes Gomes
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.